Latest news
BioLineRx reports preclinical data on GLIX1 with PARP inhibitor - Investing.comInvesting.com · Fri, 07 Aug 2026 10:13:13 GMTBioLine RX Ltd (BLRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 09:54:35 GMTPrice to sales forward of BioLineRX Ltd. – TASE:BLRX - TradingViewTradingView · Sat, 01 Aug 2026 07:05:49 GMTBioLine RX Ltd (BLRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTBLRX|BioLine RX Ltd|Price:2.710|Chg%:-0.040 - TradingKeyTradingKey · Mon, 27 Jul 2026 18:04:17 GMTBioLine RX Ltd (BLRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Mon, 27 Jul 2026 12:50:57 GMTBioLine RX Ltd (BLRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKeyTradingKey · Sun, 26 Jul 2026 23:30:00 GMT